Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea

医学 糖尿病性视网膜病变 糖尿病 内科学 蛋白尿 血糖性 视网膜病变 2型糖尿病 危险系数 2型糖尿病 英国前瞻性糖尿病研究 入射(几何) 前瞻性队列研究 置信区间 内分泌学 物理 光学
作者
Jae-Seung Yun,Tae-Seok Lim,Seon‐Ah Cha,Yu‐Bae Ahn,Ki-Ho Song,Jin A Choi,Jin Woo Kwon,Donghyun Jee,Yang Kyung Cho,Yong‐Moon Park,Seung‐Hyun Ko
出处
期刊:Diabetes & Metabolism Journal [Korean Diabetes Association]
卷期号:40 (6): 482-482 被引量:47
标识
DOI:10.4093/dmj.2016.40.6.482
摘要

We investigated clinical course and risk factors for diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM).A total of 759 patients with T2DM without DR were included from January 2001 to December 2004. Retinopathy evaluation was performed at least annually by ophthalmologists. The severity of the DR was classified into five categories according to the International Clinical Diabetic Retinopathy Severity Scales.Of the 759 patients, 523 patients (68.9%) completed the follow-up evaluation. During the follow-up period, 235 patients (44.9%) developed DR, and 32 patients (13.6%) progressed to severe nonproliferative DR (NPDR) or proliferative DR (PDR). The mean duration of diabetes at the first diagnosis of mild NPDR, moderate NPDR, and severe NPDR or PDR were 14.8, 16.7, and 17.3 years, respectively. After adjusting multiple confounding factors, the significant risk factors for the incidence of DR risk in patients with T2DM were old age, longer duration of diabetes, higher mean glycosylated hemoglobin (HbA1c), and albuminuria. Even in the patients who had been diagnosed with diabetes for longer than 10 years at baseline, a decrease in HbA1c led to a significant reduction in the risk of developing DR (hazard ratio, 0.73 per 1% HbA1c decrement; 95% confidence interval, 0.58 to 0.91; P=0.005).This prospective cohort study demonstrates that glycemic control, diabetes duration, age, and albuminuria are important risk factors for the development of DR. More aggressive retinal screening for T2DM patients diagnosed with DR should be required in order to not miss rapid progression of DR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
子铭发布了新的文献求助10
刚刚
情怀应助Baymax采纳,获得10
刚刚
刚刚
开心砖头发布了新的文献求助10
1秒前
深情安青应助科研通管家采纳,获得10
1秒前
NexusExplorer应助科研通管家采纳,获得10
1秒前
充电宝应助科研通管家采纳,获得10
1秒前
思源应助科研通管家采纳,获得10
1秒前
2秒前
2秒前
烟花应助科研通管家采纳,获得10
2秒前
所所应助科研通管家采纳,获得10
2秒前
小马甲应助科研通管家采纳,获得10
2秒前
AamirAli应助zky采纳,获得10
2秒前
英姑应助科研通管家采纳,获得10
2秒前
Hello应助科研通管家采纳,获得10
2秒前
Twonej应助科研通管家采纳,获得30
2秒前
天天快乐应助科研通管家采纳,获得10
2秒前
汉堡包应助科研通管家采纳,获得10
2秒前
深情安青应助科研通管家采纳,获得10
2秒前
充电宝应助科研通管家采纳,获得30
3秒前
脑洞疼应助科研通管家采纳,获得10
3秒前
汉堡包应助科研通管家采纳,获得10
3秒前
Twonej应助科研通管家采纳,获得30
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
852应助科研通管家采纳,获得10
3秒前
JamesPei应助科研通管家采纳,获得10
3秒前
香蕉觅云应助科研通管家采纳,获得10
3秒前
FashionBoy应助科研通管家采纳,获得10
3秒前
3秒前
科研通AI6.1应助筱菱采纳,获得10
3秒前
Twonej应助科研通管家采纳,获得30
3秒前
共享精神应助科研通管家采纳,获得10
3秒前
今后应助科研通管家采纳,获得10
4秒前
简单爱发布了新的文献求助10
4秒前
脑洞疼应助科研通管家采纳,获得10
4秒前
4秒前
JamesPei应助科研通管家采纳,获得10
4秒前
FashionBoy应助xu采纳,获得10
4秒前
Twonej应助科研通管家采纳,获得30
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6018806
求助须知:如何正确求助?哪些是违规求助? 7609979
关于积分的说明 16160469
捐赠科研通 5166597
什么是DOI,文献DOI怎么找? 2765415
邀请新用户注册赠送积分活动 1747039
关于科研通互助平台的介绍 1635433